ACETYLON PHARMACEUTICALS, INC.

Profile

Company Names

ACETYLON PHARMACEUTICALS, INC.

Addresses

SEAPORT CENTER, 70 FARGO STREET, SUITE 205, BOSTON, MA 02210

609 ALBANY STREET, 6TH FLOOR, BOSTON, MA 02118

C/O NATIONAL REGISTERED AGENTS, INC., 303 CONGRESS STREET, 2ND FL, BOSTON, MA 02210

Phone Numbers

202-421-7994
617-245-1300
617-435-2664

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$21,238,109.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-02-08 
$13,988,109.00 
$27,625,625.00 
$13,637,516.00 
Equity 
1
2009-07-24 
$7,250,000.00 
$8,000,000.00 
$750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENNETH 
 
ANDERSON 
DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  ONCOPEP, INC.   |  ONE WORLD LAB, INC.   |  C4 THERAPEUTICS, INC.   |  ASPIRIANT, LLC   |  STARTON THERAPEUTICS INC.   |  NEXTRNA THERAPEUTICS, INC.   |  WINDOW THERAPEUTICS, INC.
JAMES 
 
BRADNER 
DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  SHAPE PHARMACEUTICALS, INC.
MARC 
A. 
COHEN 
EXECUTIVE OFFICER, DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  ALTERNATIVE COMPASSION SERVICES INC   |  FREQUENCY THERAPEUTICS, INC.   |  AI PROTEINS, INC.   |  NEXTRNA THERAPEUTICS, INC.
BRUCE 
 
DOWNEY 
DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  ONCOPEP, INC.   |  C4 THERAPEUTICS, INC.
BRUCE 
L. 
DOWNEY 
DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  PUTNEY INC   |  NEWSPRING HEALTH CAPITAL III, L.P.
WALTER 
 
OGIER 
DIRECTOR, EXECUTIVE OFFICER
ACETYLON PHARMACEUTICALS, INC.   |  THETIS PHARMACEUTICALS LLC   |  ANELIXIS THERAPEUTICS, INC.   |  NOVUS THERAPEUTICS, INC.   |  ELEDON PHARMACEUTICALS, INC.
WALTER 
C. 
OGIER 
EXECUTIVE OFFICER, DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  ANELIXIS THERAPEUTICS, INC.
ELENA 
 
PROKUPETS 
DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  ONCOPEP, INC.   |  C4 THERAPEUTICS, INC.   |  AI PROTEINS, INC.   |  NEXTRNA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-08-15
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-08 
2011-02-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-08 
2009-08-10
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-07-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#